Efficacy and Safety of RTH258 Versus Aflibercept - Study 2

Clinical trial NCT02434328 · COMPLETED

Trial details

NCT number: NCT02434328
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration Choroidal Neovascularization

Start date: 2015-07-28
Primary completion: 2017-04-05
Enrollment: 1048

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.